PerpEquities

Equity · Healthcare

Zoetis Inc. (ZTS) perpetual futures

ZTS perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade ZTSUSDT.

Zoetis researches, develops, manufactures and sells veterinary pharmaceuticals, vaccines and diagnostic tools for livestock and companion animals, serving veterinary professionals, livestock producers and retail channels.

$81.10-7.9%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · MEXC (ZTS/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$12.4K
Open interest
$24.4K
Best liquidity
$37.9K
MEXC
Tightest spread
+73.4 bps
MEXC
Highest volume
$12.4K
MEXC
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $776.9M
OI / float
0.00%
Float $33.4B
Spot performance
1D-7.95%
5D+2.84%
1M+15.11%
6M-26.17%
YTD-34.74%
1Y-31.32%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeZTS/USDTTrading$81.10-21.9% APR
-0.020% every 8h
+73.4 bps$37.9K$12.4K$24.4KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 1 venues absorb $10k · Typical cost: +77.3 bps

Cheapest execution: MEXC · +77.3 bps

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

ZTS

Tightest spread

ZTS

Highest volume

ZTS

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-11-05 · next report 2027-02-11 · Updated 1h ago
All financials →

Valuation & key figures

Market cap
$33.9B
Updated 1h ago
Revenue
$9.5B
Trailing 12 months
Revenue growth
-2%
Next fiscal year
Profit margin
+26.1%
P/E
13.9
Peer P/E 29.6
P/S
3.6
Peer P/E
29.6
Similar listed perps
Free cash flow
$2.3B
Trailing 12 months
Net income
$2.5B
Trailing 12 months
Revenue estimate
$9.3B
Next fiscal year
Earnings
2027-02-11
Revenue est. $2.2B · Updated 1h ago
Dividend
$0.53
2026-10-30
Revenue (TTM)$9.51B+1.2% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)37.0%-0.6 pp vs a year agoOperating income $3.52B
Net income (TTM)$2.49B-6.2% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$2.28B+1.7% vs a year agoCapex $495M
Diluted EPS (TTM)$5.88-1.0% vs a year agoSum of the last 4 quarters
Net cash$1.35B+125.9% vs a year agoCash + short-term investments - debt
  • Last report (2026-11-05): revenue beat by 3.8%, EPS beat by 15.9%Revenue $2.39B vs $2.3B expected (+3.8%); EPS $1.75 vs $1.51 (+15.9%).
  • Revenue growth slowing: -0.4% year on yearQ3 '26 revenue $2.39B, against an average of 1.4% over the four quarters before.
  • Operating margin 37.0% (TTM), -0.6 pp on a year agoOperating income grew -0.4% while revenue grew 1.2%.
  • 13.1% of pre-tax profit is eaten by non-operating lossesPre-tax income $3.11B vs operating income $3.52B (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly

Revenue by business line

latest quarter
LineRevenuey/yShare
Horses$73M+10.6%3.1%
Dogs and Cats$1.49B-5.9%64.0%
Cattle$439M+10.0%18.8%
Swine$120M+8.1%5.2%
Poultry$108M+1.9%4.6%
Fish$98M+25.6%4.2%
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 347 lines Zoetis Inc. reported to the SEC

Next catalyst

Catalysts

Earnings
2027-02-11
Revenue est. $2.2B · Updated 1h ago
Dividend
$0.53
2026-10-30

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20266.21$9.3B-2%10
FY 20276.34$9.3B-1%10
FY 20286.76$9.7B+2%7
FY 20297.93$10.2B+7%2
FY 20308.75$10.6B+12%4
Q1 20271.50$2.3B0%8

Company events

6
2027-02-11EarningsActual - / Estimate 1.29-
2026-11-05EarningsActual 1.75 / Estimate 1.51Beat
2026-10-30Dividend$0.53-
2026-08-06EarningsActual 1.87 / Estimate 1.85Beat
2026-07-20Dividend$0.53-
2026-05-07EarningsActual 1.53 / Estimate 1.6Miss

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 6, 2026, 11:41 AM UTC

Company profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chief executive
Kristin C. Peck
Employees
14,500
IPO date
Feb 1, 2013
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei4.86
Piotroski scorei7/9
Overall ratingiA
Owner earningsi$713.61M$1.73 per share
ESG risk ratingiB-Industry rank: 104 out of 107

Rating factors

Return on equityi
5
Return on assetsi
5
Debt to equityi
4
Price to earningsi
3
Price to booki
1
Market cap history
$33.80B+4.7%Aug 26 – Nov 26
$29.79B$32.01B$34.24BHigh: $34.24B · 2026-11-02Low: $29.79B · 2026-09-21Latest: $33.80B · 2026-11-05Aug 26Sep 26Oct 26Nov 26
Latest: $33.80B · 2026-11-05High: $34.24B · 2026-11-02Low: $29.79B · 2026-09-21
Largest fund holders
FundWeightShares held
VTI0.04%11.8M
VOO0.04%10.9M
VO0.26%8M
IVV0.06%5.5M
1657.T0.04%5.5M
XSP.TO0.05%5.5M
SPY0.06%5.1M
VSCA.S0.14%4.3M
FXAIX0.04%4.2M
VCPA.S0.08%4M
MOAT2.69%3.7M
VTV0.1%3.5M

Analyst track record

How the analysts covering ZTS have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings81206
Analysts2023
Buy / hold / sell38 / 43 / 0148 / 58 / 0
Upgrades / downgrades / initiations0 / 7 / 40 / 9 / 8
Price targets hit / missed5 / 61 (8%)5 / 173 (3%)
Avg. return after a rating (TipRanks)-29.0%-48.3%
Best / worst call+11.0% / -56.8%+11.0% / -68.4%

After buy calls on this stock: not enough measured cases yet

Latest ratings

DateAnalystCallTarget
Nov 6, 2026Scott SchoenhausKeyBancHoldMaintained–
Nov 5, 2026Jonathan BlockStifel NicolausHoldMaintained$85.00
Oct 30, 2026Erin WrightMorgan StanleyBuyMaintained$82.00
Oct 27, 2026Andrea AlfonsoUBSHoldReiterated$85.00
Oct 20, 2026Keith DevasJefferiesHoldDowngraded$83.00

TipRanks data · computed Nov 6, 2026 · 81 ratings

Frequently asked questions

Where can I trade ZTS perpetual futures?

Zoetis Inc. (ZTS) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade ZTS around the clock?

Yes. Unlike the underlying stock, ZTS perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on ZTS perpetuals?

Right now the ZTS perp funding rate is -21.9% annualized (venue median), ranging from -21.9% to -21.9% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the ZTS perp price compare to the Zoetis Inc. stock?

The venue-median ZTS perp mark is $81.1 versus a reference stock price of $81.1, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a ZTS perpetual future?

A ZTS perpetual is a derivative that tracks the price of Zoetis Inc. with no expiry date. It lets you take long or short exposure to Zoetis Inc. on crypto venues, around the clock.

What is ZTSUSDT perpetual?

ZTSUSDT is the symbol most crypto exchanges use for the Zoetis Inc. perpetual settled in USDT (Tether). It tracks the ZTS share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

ZTS perpetuals · perpequities.comZTS perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/zts-perp"><img src="https://perpequities.com/badge/zts-perp.svg" width="240" height="64" alt="ZTS perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of ZTS perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for ZTS — one email every Sunday.

Watchlist and alerts

Price and funding alerts for ZTS, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X